logo

For the Inventor, By the Inventor

Suita, Japan

National Cerebral and Cardiovascular Center


USPTO Granted Patents = 49



Forward Citations = 272

Loading Chart...
Loading Chart...

123 inventors (with patents filed for the assignee):

goldMedal Kenji Kangawa (9 out of 32 patents)

silverMedal Yasuhide Nakayama (8 out of 8 patents)

bronzeMedal Masaru Sugimachi (8 out of 10 patents)

4.  Kenji Sunagawa (6 out of 13 patents)

5.  Tetsuji Yamaoka (5 out of 6 patents)

6.  Takashi Nojiri (5 out of 5 patents)

7.  Takayuki Sato (4 out of 12 patents)

8.  Yasushi Nemoto (4 out of 6 patents)

9.  Tatsuo Nishihara (4 out of 10 patents)

10.  Koji Takizawa (4 out of 10 patents)

11.  Kazuo Nakazawa (4 out of 6 patents)

12.  Hiroshi Hosoda (4 out of 10 patents)

13.  Masashi Inagaki (4 out of 4 patents)

14.  Nobuhiro Suzuki (3 out of 26 patents)

15.  Ryosuke Iwai (3 out of 3 patents)


Core Competencies:
Cerebral Infarction Treatment
Antitumor Effect Potentiator
Dementia Treatment
Myocardial Analysis
Amniotic Mesenchymal Stromal Cells
Peptide Therapeutics
Valved Stent Technology
Cardiac Pacing Systems
Dyslipidemia Treatment
Extracorporeal Ultrasonic Irradiation
Blood Anticoagulant Materials
Tissue Engineering

49 patents:

1. 12201461 - Cerebral infarction treatment support system (2025-01-21),
2. 12186350 - Antitumor effect potentiator (2025-01-07),
3. 11925633 - Drug for preventing and/or treating dementia (2024-03-12),
4. 11697797 - Manufacturing method of a cell structure (2023-07-11),
5. 11464441 - Myocardial analysis apparatus and myocardial excitation detection apparatus (2022-10-11),
6. 11389486 - Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent (2022-07-19),
7. 11273222 - Antisense nucleic acid targeting PCSK9 (2022-03-15),
8. 11253626 - Use for peptide uniquely binding to vascular endothelial cells, and peptide (2022-02-22),
9. 11149252 - Cell mass, cell structure, and three-dimensional tissue body (2021-10-19),
10. 10898098 - Myocardial excitation determining apparatus (2021-01-26),
11. 10624555 - Myocardial analysis apparatus and myocardial excitation detection apparatus (2020-04-21),
12. 10550153 - Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof (2020-02-04),
13. 10471179 - Method of producing a film connective tissue body using a connective tissue body formation substrate (2019-11-12),
14. 10441611 - Method for producing amniotic mesenchymal stromal cell composition, method for cryopreserving the same, and therapeutic agent (2019-10-15),
15. 10351600 - Peptide and complex of same, scaffold for tissue repair and surface treatment method for same, and surface treatment solution or set of treatment solutions (2019-07-16),
The National Cerebral and Cardiovascular Center (NCVC) is a leading medical institution in Japan that specializes in the treatment of cerebral and cardiovascular diseases. With a team of highly skilled medical professionals and state-of-the-art facilities, NCVC aims to provide advanced medical care, conduct research, and educate healthcare professionals. Located in Suita, Osaka, NCVC offers a wide range of services including diagnosis, treatment, rehabilitation, and preventive care for patients suffering from conditions such as strokes, heart diseases, and aneurysms.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

...
49 Patents

#2 in Suita

#1,702 in Japan

#13,874 in the World

...
Suita, Japan

National Cerebral and Cardiovascular Center

Forward Citations = 272

123 inventors:

goldMedal Kenji Kangawa (9 out of 32 patents)

silverMedal Yasuhide Nakayama (8 out of 8 patents)

bronzeMedal Masaru Sugimachi (8 out of 10 patents)

4.  Kenji Sunagawa (6 out of 13 patents)

5.  Tetsuji Yamaoka (5 out of 6 patents)

Please report any incorrect information to support@idiyas.com
Loading…